Is Cannabis Use a Contributory Cause of Psychosis?
The Canadian Journal of Psychiatry August 1, 2006 DOI: 10.1177/070674370605100903 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Review Longitudinal Peer reviewed |
|---|---|
| Topics | Cannabis |
| Key findings | Regular cannabis use predicts an increased risk of schizophrenia diagnosis or psychotic symptoms, persisting after controlling for confounders. The authors propose that cannabis precipitates schizophrenia in vulnerable individuals, supported by biological plausibility. |
Abstract
Objective: To assess whether cannabis use in adolescence and young adulthood is a contributory cause of schizophreniform psychosis in that it may precipitate psychosis in vulnerable individuals.
Method: We reviewed longitudinal studies of adolescents and young adults that examined the relations between self-reported cannabis use and the risk of diagnosis with a psychosis or of reporting psychotic symptoms. We also reviewed studies that controlled for potential confounders, such as other forms of drug use and personal characteristics that predict an increased risk of psychosis. We assessed evidence for the biological plausibility of a contributory causal relation.
Results: Evidence from 6 longitudinal studies in 5 countries shows that regular cannabis use predicts an increased risk of a schizophrenia diagnosis or of reporting symptoms of psychosis. These relations persisted after controlling for confounding variables, such as personal characteristics and other drug use. The relation did not seem to be a result of cannabis use to self-medicate symptoms of psychosis. A contributory causal relation is biologically plausible because psychotic disorders involve disturbances in the dopamine neurotransmitter systems with which the cannabinoid system interacts, as demonstrated by animal studies and one human provocation study.
Conclusion: It is most plausible that cannabis use precipitates schizophrenia in individuals who are vulnerable because of a personal or family history of schizophrenia.
Comparable studies
Other narrative reviews on cannabis, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| Causal association between cannabis and psychosis: examination of the evidence | 2004 | Review | |
| Cannabis sativa: A comprehensive ethnopharmacological review of a medicinal plant with a long history. General (historical and pharmacological review) | 2018 | Review | |
| Psychiatric effects of cannabis | 2001 | Review | |
| Beyond THC: The New Generation of Cannabinoid Designer Drugs | 2011 | Review | |
| Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug | 2006 | Review |
Citations in the library
Cited by 13
- Continued cannabis use and risk of incidence and persistence of psychotic symptoms: 10 year follow-up cohort study BMJ March 1, 2011
- Should Burden of Disease Estimates Include Cannabis Use as a Risk Factor for Psychosis? PLoS Medicine September 28, 2009
- Early cannabis use and its relation to the development of psychiatric disorders: a review Salud Mental December 12, 2017
- Cannabis use and psychosis: the origins and implications of an association Advances in Psychiatric Treatment October 31, 2007
- Epidemiological and biological mechanisms of cannabis as cause of psychosis 2012
and 8 more in the library
Cites 16
- Cannabis-induced psychosis and subsequent schizophrenia-spectrum disorders: follow-up study of 535 incident cases The British Journal of Psychiatry November 30, 2005
- New Perspectives in the Studies on Endocannabinoid and Cannabis: Cannabinoid Receptors and Schizophrenia Journal of Pharmacological Sciences 2004
- Cannabinoid ‘model’ psychosis, dopamine–cannabinoid interactions and implications for schizophrenia Cambridge University Press eBooks May 27, 2004
- Is there a specific ‘cannabis psychosis’? Cambridge University Press eBooks May 27, 2004
- Cannabis Psychotic Disorder American Journal on Addictions 1994
and 11 more in the library